Because regulatory approval of cognitive enhancement drugs is likely, physicians may want to consider whether they would condone the practice for restoration of function only or for enhancement purposes as well.
The WHO Clinical Staging System for HIV/AIDS allows physicians in resource-limited settings to make clinical decisions based on patient clinical features instead of laboratory tests.